| Literature DB >> 25957871 |
Obioma Nwankwo1,2, Hana Mekdash3, Dwi Seno Kuncoro Sihono4, Frederik Wenz5, Gerhard Glatting6.
Abstract
BACKGROUND: A knowledge-based radiation therapy (KBRT) treatment planning algorithm was recently developed. The purpose of this work is to investigate how plans that are generated with the objective KBRT approach compare to those that rely on the judgment of the experienced planner.Entities:
Mesh:
Year: 2015 PMID: 25957871 PMCID: PMC4433067 DOI: 10.1186/s13014-015-0416-6
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
A MONACO® planning template for prostate VMAT at the Universitätsmedizin Mannheim. P + SB = prostate and seminal vesicles
| Structure | Cost function | Reference dose (cGy) | Isoconstraint |
|---|---|---|---|
| P + SB | Target EUD | 6000.0 | |
| Quadratic overdose | 6000.0 | 70.0 | |
| Quadratic underdose | 6000.0 | 70.0 | |
| Bladder | Parallel | 3000.0 | 40.0 |
| Serial | 3500.0 | ||
| Rectum | Parallel | 3000.0 | 30.0 |
| Quadratic overdose | 3000.0 | 50.0 | |
| Patient | Quadratic overdose | 3500.0 | 120.0 |
| Quadratic overdose | 2200.0 | 60.0 | |
| Conformality | 0.7 |
Fig. 1Bladder dose of the KBRT and expert plans. The central line of each box shows the median value, while the upper and lower edges represent the 25th (Q1) and 75th (Q3) percentiles respectively. The whiskers extend to values that are not considered as outliers (approximately mean ± 2.7 times standard deviation for normally distributed data). The individual pluses (+) are the extreme values that are considered as outliers. The Wilcoxon test shows that the KBRT plans achieved significantly lower dose to the bladder (at D30) when compared to the expert plans
Fig. 2Rectal dose of the KBRT and expert plans. The Wilcoxon test results showed that the expert plans achieved significantly lower dose to the rectum (at D30 and D10) when compared to the KBRT plans
Summary of the organ doses (mean ± standard deviation) of the KBRT and expert plans. All doses are normalized to dose that is prescribed to the target volume. The Wilcoxon test shows significantly lower bladder dose for the KBRT plans (at D30), as well as lower rectal dose (at D10 and D30) for the expert plans
| Organ volume [%] | Bladder | Rectum | ||||
|---|---|---|---|---|---|---|
| Mean organ dose of KBRT plans [%] | Mean organ dose of expert plans [%] | Mean organ dose difference (KBRT - expert) | Mean organ dose of KBRT plans [%] | Mean organ dose of expert plans [%] | Mean organ dose difference (KBRT- expert) | |
| 10 | 98.4 ± 4.4 | 98.3 ± 5.0 | 0.1 ± 2.9 | 93.0 ± 7.9 | 90.1 ± 9.5 | 3.0 ± 4.5 |
| 30 | 70 ± 25 | 74 ± 22 | −3.0 ± 6.3 | 63 ± 17 | 57 ± 16 | 5.6 ± 8.1 |
| 50 | 44 ± 30 | 46 ± 29 | −2.7 ± 9.1 | 39 ± 13 | 36.8 ± 9.9 | 2.4 ± 7.5 |
| 70 | 24 ± 22 | 24 ± 19 | 0.0 ± 7.1 | 24.6 ± 9.0 | 24.8 ± 7.1 | −0.3 ± 5.4 |
| 90 | 11 ± 12 | 9.8 ± 8.7 | 1.0 ± 6.2 | 11.9 ± 6.2 | 12.6 ± 6.8 | −0.7 ± 3.4 |